About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
SIVELESTAT (ID 27452) exhibits a broad and high‑complexity biochemical activity spectrum, modulating hierarchical signalling cascades, deep enzymatic networks, mitochondrial functional architecture, cytoskeletal integrity, transcription‑factor coordination and multi‑axis stress‑response systems. Its molecular conformation supports interaction with catalytic pockets, allosteric microdomains, transmembrane helices, regulatory scaffolds, ion‑channel architectures and redox‑buffering systems, producing wide‑ranging effects across metabolic, genomic, structural and electrophysiological layers.
Mechanistically, SIVELESTAT may alter phosphorylation topologies, reshape signalling‑cascade propagation (ERK, JNK, MAPK, PI3K–AKT), amplify or suppress second‑messenger concentrations (Ca²⁺, cAMP, IP₃, DAG), modify mitochondrial membrane polarity, shift ATP/ADP cycling behaviour, regulate ROS‑leakage thresholds and influence global metabolic flux distribution. Its capacity to integrate signals from cytosolic, organelle‑bound and membrane‑anchored proteins makes it suitable for advanced mechanistic interrogation.
High‑Level Research Applications
- Deep kinome‑mapping & systems‑level pathway‑interference analysis
- Structural docking, ligand‑stability modelling & conformational dynamics
- Mitochondrial‑stress analysis including ETC complex modelling
- UPR, ER‑stress & integrated autophagy/mitophagy evaluation
- Multi‑omics network reconstruction (RNA‑seq, phosphoproteomics, metabolomics)
- Membrane‑dynamics and cytoskeletal mechanotransduction studies
- Advanced cell‑fate modelling across apoptosis, necroptosis & ferroptosis axes
- Predictive SAR/QSAR pipelines using machine‑learning optimisation
Toxicodynamics & Cellular Risk Spectrum
- Rapid ROS escalation & antioxidant‑system saturation
- Mitochondrial fragmentation or ETC suppression
- Severe ionic‑flux dysregulation (Ca²⁺, Na⁺, K⁺)
- Cytoskeletal collapse & membrane‑integrity compromise
- Inflammatory upregulation (NF‑κB, STAT, IRF)
- Activation of programmed‑cell‑death pathways
- Epigenetic drift involving methylation & acetylation instability
For expert laboratory use only — not for biological or therapeutic exposure.
Datasheet
| Molecular Formula | C20H22N2O7S |
|---|---|
| Molecular Weight | 434.5 g/mol |
| CAS Number | 127373-66-4 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Sivelestat; 127373-66-4; Ono-5046; 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid; LY544349 |
| IUPAC/Chemical Name | 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid |
| InChl Key | BTGNGJJLZOIYID-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
